Global Survey on Pancreatic Surgery During the COVID-19 Pandemic.
Adult
Betacoronavirus
COVID-19
Clinical Decision-Making
Consensus
Coronavirus Infections
/ epidemiology
Female
Humans
Internationality
Male
Middle Aged
Pancreatic Neoplasms
/ surgery
Pandemics
Patient Safety
Pneumonia, Viral
/ epidemiology
Practice Patterns, Physicians'
/ statistics & numerical data
SARS-CoV-2
Surveys and Questionnaires
Journal
Annals of surgery
ISSN: 1528-1140
Titre abrégé: Ann Surg
Pays: United States
ID NLM: 0372354
Informations de publication
Date de publication:
08 2020
08 2020
Historique:
entrez:
18
7
2020
pubmed:
18
7
2020
medline:
4
8
2020
Statut:
ppublish
Résumé
The aim of this study was to clarify the role of pancreatic surgery during the COVID-19 pandemic to optimize patients' and clinicians' safety and safeguard health care capacity. The COVID-19 pandemic heavily impacts health care systems worldwide. Cancer patients appear to have an increased risk for adverse events when infected by COVID-19, but the inability to receive oncological care seems may be an even larger threat, particularly in case of pancreatic cancer. An online survey was submitted to all members of seven international pancreatic associations and study groups, investigating the impact of the COVID-19 pandemic on pancreatic surgery using 21 statements (April, 2020). Consensus was defined as >80% agreement among respondents and moderate agreement as 60% to 80% agreement. A total of 337 respondents from 267 centers and 37 countries spanning 5 continents completed the survey. Most respondents were surgeons (n = 302, 89.6%) and working in an academic center (n = 286, 84.9%). The majority of centers (n = 166, 62.2%) performed less pancreatic surgery because of the COVID-19 pandemic, reducing the weekly pancreatic resection rate from 3 [interquartile range (IQR) 2-5] to 1 (IQR 0-2) (P < 0.001). Most centers screened for COVID-19 before pancreatic surgery (n = 233, 87.3%). Consensus was reached on 13 statements and 5 statements achieved moderate agreement. This global survey elucidates the role of pancreatic surgery during the COVID-19 pandemic, regarding patient selection for the surgical and oncological treatment of pancreatic diseases to support clinical decision-making and creating a starting point for further discussion.
Sections du résumé
OBJECTIVE
The aim of this study was to clarify the role of pancreatic surgery during the COVID-19 pandemic to optimize patients' and clinicians' safety and safeguard health care capacity.
SUMMARY BACKGROUND DATA
The COVID-19 pandemic heavily impacts health care systems worldwide. Cancer patients appear to have an increased risk for adverse events when infected by COVID-19, but the inability to receive oncological care seems may be an even larger threat, particularly in case of pancreatic cancer.
METHODS
An online survey was submitted to all members of seven international pancreatic associations and study groups, investigating the impact of the COVID-19 pandemic on pancreatic surgery using 21 statements (April, 2020). Consensus was defined as >80% agreement among respondents and moderate agreement as 60% to 80% agreement.
RESULTS
A total of 337 respondents from 267 centers and 37 countries spanning 5 continents completed the survey. Most respondents were surgeons (n = 302, 89.6%) and working in an academic center (n = 286, 84.9%). The majority of centers (n = 166, 62.2%) performed less pancreatic surgery because of the COVID-19 pandemic, reducing the weekly pancreatic resection rate from 3 [interquartile range (IQR) 2-5] to 1 (IQR 0-2) (P < 0.001). Most centers screened for COVID-19 before pancreatic surgery (n = 233, 87.3%). Consensus was reached on 13 statements and 5 statements achieved moderate agreement.
CONCLUSIONS
This global survey elucidates the role of pancreatic surgery during the COVID-19 pandemic, regarding patient selection for the surgical and oncological treatment of pancreatic diseases to support clinical decision-making and creating a starting point for further discussion.
Identifiants
pubmed: 32675507
doi: 10.1097/SLA.0000000000004006
pii: 00000658-202008000-00027
pmc: PMC7268883
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e87-e93Références
World Health Organization (WHO). Coronavirus disease 2019 (COVID-19): situation report, 51. 2020. Available at: https://apps.who.int/iris/bitstream/handle/10665/331475/nCoVsitrep11Mar2020-eng.pdf?sequence=1&isAllowed=y. Accessed on: March 28, 2020.
Grasselli G, Pesenti A, Cecconi M. Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response. JAMA 2020; doi:10.1001/jama.2020.4031.
doi: 10.1001/jama.2020.4031
Pellino G, Spinelli A. How COVID-19 outbreak is impacting colorectal cancer patients in italy: a long shadow beyond infection. Dis Colon Rectum 2020; doi:10.1097/DCR. 0000000000001685.
doi: 10.1097/dcr.
Liang W, Guan W, Chen R, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol 2020; 21:335–337.
Wang H, Zhang L. Risk of COVID-19 for patients with cancer. Lancet Oncol 2020; 21:e181doi:10.1016/S1470-2045(20)30149-2.
doi: 10.1016/s1470-2045(20)30149-2
Kutikov A, Weinberg DS, Edelman MJ, Horwitz EM, Uzzo RG, Fisher RI. A War on Two Fronts: Cancer Care in the Time of COVID-19. Annals of Internal Medicine 2020. Available at: https://annals.org/aim/fullarticle/2764022/war-two-fronts-cancer-care-time-covid19?fbclid=IwAR2ouycwL74nYSPEIQTs2DALPQ73ZK3FWTnQh21FkBZOpjef18gldMYXSw4. Accessed on: March 28, 2020.
Ueda M, Martins R, Hendrie PC, et al. Managing cancer care during the COVID-19 pandemic: agility and collaboration toward a common goal. J Natl Compr Canc Netw 2020. 1–4. doi:10.6004/jnccn.2020.7560.
doi: 10.6004/jnccn.2020.7560
Bosman FT, Carneiro F, Hruban RH, et al. WHO Classification of Tumors of the Digestive System (4th edition). Lyon: IARC Press; 2010.
Tanaka M, Fernandez-del Castillo C, Adsay V, et al. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology 2012; 12:183–197.
Hata T, Motoi F, Ishida M, et al. Effect of hospital volume on surgical outcomes after pancreaticoduodenectomy: a systematic review and meta-analysis. Ann Surg 2016; 263:664–672.
Society of Surgical Oncology (SSO). Resource for Management Options of GI and HPB Cancers. 2020. Available at: https://www.surgonc.org/wp-content/uploads/2020/03/GI-and-HPB-Resource-during-COVID-19-4.6.20.pdf. Accessed on: April 6, 2020.
Society of American Gastrointestinal and Endoscopic Surgeons (SAGES). SAGES and EAES recommendations regarding surgical response to COVID-19 crisis. Available at: https://www.sages.org/recommendations-surgical-response-covid-19/ Accessed on: April 11, 2020.
American College of Surgeons (ACS). COVID-19: Elective Case Triage Guidelines for Surgical Care 2020. Available at: https://www.facs.org/covid-19/clinical-guidance/elective-case. Accessed at: April 5, 2020.
Johnson AP, Altmark RE, Weinstein MS, et al. Predicting the risk of postoperative respiratory failure in elective abdominal and vascular operations using the National Surgical Quality Improvement Program (NSQIP) Participant Use Data File. Ann Surg 2017; 266:968–974.
Choi SH, Kwon TG, Chung SK, et al. Surgical smoke may be a biohazard to surgeons performing laparoscopic surgery. Surg Endosc 2014; 28:2374–2380.
Kwak HD, Kim SH, Seo YS, et al. Detecting hepatitis B virus in surgical smoke emitted during laparoscopic surgery. Occup Environ Med 2016; 73:857–863.
Oba A, Croce C, Hosokawa P, et al. Prognosis based definition of resectability in pancreatic cancer: a road map to new guidelines. Ann Surg 2020; doi:10.1097/SLA.0000000000003859.
doi: 10.1097/sla.0000000000003859
Curigliano G. The Treatment of Patients With Cancer and Containment of COVID-19: Experiences From Italy. ASCO Daily News 2020. Available at: https://dailynews.ascopubs.org/do/10.1200/ADN.20.200068/full/. Accessed on: March 28, 2020.
van der Geest LGM, van Rijssen LB, Molenaar IQ, et al. Volume–outcome relationships in pancreatoduodenectomy for cancer. HPB (Oxford) 2016; 18:317–324.
van Rijssen LB, Zwart MJ, van Dieren S, et al. Variation in hospital mortality after pancreatoduodenectomy is related to failure to rescue rather than major complications: a nationwide audit. HPB (Oxford) 2018; 20:759–767.
Alp E, Bijl D, Bleichrodt RP, et al. Surgical smoke and infection control. J Hosp Infect 2006; 62:1–5.
Zheng MH, Boni L, Fingerhut A. Minimally invasive surgery and the Novel Coronavirus outbreak: lessons learned in China and Italy. Ann Surg 2020; doi:10.1097/SLA.0000000000003924.
doi: 10.1097/sla.0000000000003924